Also, overexpression of B4GalT-5 significantly suppressed arsenic trioxide (As2O3)-induced apoptosis in glioma cells, suggesting the use of B4GalT-5 inhibitors in combination therapy for gliomas [36]. The gene discussed is B4GALT5; the disease is central nervous system cancer.